Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Exemplar
98.8
%
| 12 | 44.7 % | 6 | 98.8 % | -48.81% |
Biopharmaceuticals
1.2
%
| 15 | 55.3 % | 0 | 1.2 % | -99.50% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 27 | 99.1 % | 6 | 100.0 % | -76.66% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 19-12-31 |
Harry Thomasian
DFI | Director of Finance/CFO | 62 | 21-09-30 |
Randal Kirk
CHM | Chairman | 70 | 08-01-31 |
Amy Lankford
CTO | Chief Tech/Sci/R&D Officer | - | - |
Rutul Shah
COO | Chief Operating Officer | - | - |
Investor Relations Contact | - | 17-12-31 | |
Jim Shaffer
PRN | Corporate Officer/Principal | - | - |
Rob Russell
HRO | Human Resources Officer | - | - |
Don Lehr
LAW | General Counsel | 49 | 08-12-31 |
Corporate Officer/Principal | 59 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Randal Kirk
CHM | Chairman | 70 | 08-01-31 |
Dean Mitchell
BRD | Director/Board Member | 68 | 09-02-28 |
Jeffrey Perez
PRN | Corporate Officer/Principal | 52 | 14-07-31 |
Fred Hassan
BRD | Director/Board Member | 78 | 16-06-29 |
Jeffrey Kindler
BRD | Director/Board Member | 68 | 11-11-27 |
Cesar Alvarez
BRD | Director/Board Member | 76 | 08-01-31 |
James Turley
BRD | Director/Board Member | 68 | 14-04-15 |
Steven Frank
BRD | Director/Board Member | 64 | 08-01-31 |
Director/Board Member | 56 | 17-04-24 | |
Helen Sabzevari
CEO | Chief Executive Officer | 62 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 259,899,121 | 223,411,404 ( 85.96 %) | 7,479,431 ( 2.878 %) | 85.96 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |